Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glutamate Reducing Interventions in Schizophrenia

NCT03321617 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT03321617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03321617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glutamate Reducing Interventions in Schizophrenia
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 1
Overall status
Completed
Start date
April 17, 2018
Completion date
March 13, 2020
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical high risk for psychosis